+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years +
MALE
ID07135102

Phase 1 Study of 225Ac-PSMA-XT Injection for Safety and Effectiveness in Men with Metastatic Castration-Resistant Prostate Cancer

Led by Xiaorong Sun · Updated on 2025-08-24

40

Participants Needed

1

Research Sites

21 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and effectiveness of a new drug called 225Ac-labeled PSMA ligand PSMA-XT for treating metastatic castration-resistant prostate cancer mCRPC. This phase 1 clinical study focuses on men with mCRPC who have progressed despite prior treatments including hormone therapies and chemotherapy. The goal is to understand how well this drug works and how safe it is for patients with this advanced prostate cancer. Participants in this study receive the 225Ac-PSMA-XT drug through injections given every six weeks. This treatment is being carefully monitored for any side effects or toxicities over the course of the study. The study does not use a placebo or comparison group all enrolled patients receive the experimental treatment. The study period includes assessments up to two years to observe treatment effects and safety. During the study, participants will undergo regular evaluations including scans, blood tests, and clinical exams to monitor their cancer status and any side effects. Researchers will track prostate-specific antigen PSA responses, disease progression, overall response rates, and the duration of any benefits. Safety is closely watched by recording any adverse events and dose-limiting toxicities. Patients will be followed for up to two years to gather comprehensive information on treatment impact and tolerability.

CONDITIONS

Brief Title

A Clinical Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of [225Ac]Ac-PSMA-XT Injection in Patients With Metastatic Castration-resistant Prostate Cancer

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here